All in one place: get the latest guidance on Nirsevimab and other resources to prepare your practice for this year’s RSV season.

Nirsevimab (Beyfortus)

Nirsevimab (Beyfortus) is a monoclonal antibody product that helps prevent serious illness from RSV. Like other medications, the dose is determined by a child's weight. Protection is given right away following the shot.

Pediatric practices should understand the products, when to recommend/administer them and prepare offices for their availability.

Indiana Department of Health Information and Planning Checklist

Handy information for a variety of practice setting on how to get ready for the 2023 RSV season.

Ordering and Product Information

Considerations related to financing, product cost, and storage.

Administration, Dosing, and Schedule

Get the latest info on dosing guidance and how to administer.

Payment and Coding

This is the information you need to get paid.

Frequently Asked Questions

Find out what people are asking and get the answers you need.

Still Need Help? Webinar on 9/26

Join PMI's Paul Vanchiere and PCC's Chip Hart to hear more about how to best get your practice set up to succeed. This will be particularly helpful for independent practices.